相似文献
1
GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model.
Cancer Cell. 2008 Feb;13(2):141-52. doi: 10.1016/j.ccr.2008.01.011.
2
Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.
Mol Cell Biol. 2011 Nov;31(22):4609-22. doi: 10.1128/MCB.05766-11. Epub 2011 Sep 19.
3
GATA-3 and the regulation of the mammary luminal cell fate.
Curr Opin Cell Biol. 2008 Apr;20(2):164-70. doi: 10.1016/j.ceb.2008.02.003. Epub 2008 Mar 21.
4
GATA3 in development and cancer differentiation: cells GATA have it!
J Cell Physiol. 2010 Jan;222(1):42-9. doi: 10.1002/jcp.21943.
5
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation.
Nat Cell Biol. 2007 Feb;9(2):201-9. doi: 10.1038/ncb1530. Epub 2006 Dec 24.
6
Utility of GATA-3 in the work-Up of breast adenocarcinoma and its differential diagnosis in serous effusions:: A Cell-Block Microarray Study.
Diagn Cytopathol. 2016 Sep;44(9):731-6. doi: 10.1002/dc.23521. Epub 2016 Jun 24.
7
GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland.
Cell. 2006 Dec 1;127(5):1041-55. doi: 10.1016/j.cell.2006.09.048.
8
MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.
J Biol Chem. 2019 Oct 25;294(43):15808-15825. doi: 10.1074/jbc.RA119.010800. Epub 2019 Sep 6.
9
3/ drives aggressive breast cancer progression by down-regulation of GATA3 expression.
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3169-3174. doi: 10.1073/pnas.1701690114. Epub 2017 Mar 3.
10
GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis.
Oncogene. 2017 Oct 5;36(40):5567-5575. doi: 10.1038/onc.2017.165. Epub 2017 Jun 5.
引用本文的文献
1
GATA3 promotes ferroptosis resistance by repressing integrin β1 signaling.
Proc Natl Acad Sci U S A. 2025 Aug 26;122(34):e2427304122. doi: 10.1073/pnas.2427304122. Epub 2025 Aug 19.
2
Discovery of epigenetically silenced tumour suppressor genes in aggressive breast cancer through a computational approach.
NAR Cancer. 2025 Jun 18;7(2):zcaf020. doi: 10.1093/narcan/zcaf020. eCollection 2025 Jun.
3
Pioneering new enhancers by GATA3: role of facilitating transcription factors and chromatin remodeling.
Nucleic Acids Res. 2025 Jun 6;53(11). doi: 10.1093/nar/gkaf473.
4
Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes.
Breast Cancer Res Treat. 2025 May 29. doi: 10.1007/s10549-025-07710-w.
5
X-Linked Cancer-Associated Polypeptide (XCP) from Cooperates with PHF8 to Regulate Gene Expression and Cellular Pathways in Breast Cancer.
bioRxiv. 2025 Mar 25:2025.03.21.644649. doi: 10.1101/2025.03.21.644649.
6
Exploring TGF-β Signaling in Cancer Progression: Prospects and Therapeutic Strategies.
Onco Targets Ther. 2025 Feb 18;18:233-262. doi: 10.2147/OTT.S493643. eCollection 2025.
7
Mechanisms of Regulation of Cell Fate in Breast Development and Cancer.
Adv Exp Med Biol. 2025;1464:167-184. doi: 10.1007/978-3-031-70875-6_10.
8
Regulatory mechanisms of steroid hormone receptors on gene transcription through chromatin interaction and enhancer reprogramming.
Cell Oncol (Dordr). 2024 Dec;47(6):2073-2090. doi: 10.1007/s13402-024-01011-y. Epub 2024 Nov 14.
9
Evaluation of breast-specific marker expression in metastatic breast cancers: Correlation with subtype switch.
Histopathology. 2025 Mar;86(4):536-546. doi: 10.1111/his.15358. Epub 2024 Oct 31.
10
GATA3 and markers of epithelial-mesenchymal transition predict long-term benefit from tamoxifen in ER-positive breast cancer.
NPJ Breast Cancer. 2024 Sep 6;10(1):78. doi: 10.1038/s41523-024-00688-6.
本文引用的文献
1
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.
Genome Biol. 2007;8(5):R76. doi: 10.1186/gb-2007-8-5-r76.
2
GATA-3 - not just for Th2 cells anymore.
Cell Mol Immunol. 2007 Feb;4(1):15-29.
3
The prognostic role of a gene signature from tumorigenic breast-cancer cells.
N Engl J Med. 2007 Jan 18;356(3):217-26. doi: 10.1056/NEJMoa063994.
4
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation.
Nat Cell Biol. 2007 Feb;9(2):201-9. doi: 10.1038/ncb1530. Epub 2006 Dec 24.
5
GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland.
Cell. 2006 Dec 1;127(5):1041-55. doi: 10.1016/j.cell.2006.09.048.
6
Cancer metastasis: building a framework.
Cell. 2006 Nov 17;127(4):679-95. doi: 10.1016/j.cell.2006.11.001.
7
Candidate regulators of mammary branching morphogenesis identified by genome-wide transcript analysis.
Dev Dyn. 2006 Dec;235(12):3404-12. doi: 10.1002/dvdy.20978.
8
Generation of a functional mammary gland from a single stem cell.
Nature. 2006 Jan 5;439(7072):84-8. doi: 10.1038/nature04372.
9
Purification and unique properties of mammary epithelial stem cells.
Nature. 2006 Feb 23;439(7079):993-7. doi: 10.1038/nature04496. Epub 2006 Jan 4.
10
Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis.
Cancer Res. 2005 Dec 15;65(24):11259-64. doi: 10.1158/0008-5472.CAN-05-2495.
Zotero 插件